Table 1
From: Anakinra (Kineret) in psoriasis and psoriatic arthritis: a single-center, open-label, pilot study
|  | Patient assessment of disease activity (0–3) | Physician assessment of disease activity (0–3) | Tender joint score (0–78) | Swollen joint score (0–76) | Patient assessment of disease activity on VAS | Patient assessment of pain on VAS | PASI score | Erythrocyte sedimentation rate | C-reactive protein |
|---|---|---|---|---|---|---|---|---|---|
Baseline | 2.14 (1–3) | 2.28 (1–3) | 24 (11–38) | 20 (7–29) | 61 (27–85) | 61 (21–90) | 5.21% (1–11) | 27 (3–78) | 33 (4–70) |
Week 12 | 1.7 (1–3) | 1.7 (1–3) | 16 (12–21) | 11 (5–25) | 43 (12–70) | 46 (20–71) | 4.5% (0–8) | 18 (2–46) | 13 (4–29) |